Raises $60 Million Series C And Receives FDA Clearance For Smartphone-Based Diagnostic Test

Today,, an Israel-based healthtech startup that turns smartphone cameras into urine-testing medical devices, has announced a $60 million Series C funding round. The company has also received FDA clearance from the U.S. Food and Drug Administration (FDA) for its smartphone-based test to be used in the aid of diagnosing chronic kidney disease (CKD), which affects over 35 million Americans.

Read the full article in Forbes.

Could The NHS Really Sell Its Data For $12 Billion?

A new report by consulting firm EY suggests that if the U.K. National Health Service (NHS) datasets were put to use, their value could be up to £9.6 billion ($12 billion) per year. This data is held within 55 million patient records and according to the report, a typical electronic health record is worth about £100 ($125), while one that’s linked to detailed genomic data can fetch as much as £5,000 ($6,200). That means an overall value of £5 billion ($6.2 billion) to commercial partners and £4.6 billion ($5.7 billion) per year in health economic benefits to patients.

Read the full article on Forbes.